MSCA-ITN-2019
MSCA-ITN-2019
Programme: H2020
166 projects · €582,545,387 total EU contribution (project-level) · 797 participating organizations · 37 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€582,545,387
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (157)
- France (91)
- Spain (77)
- UK (77)
- Italy (71)
- Netherlands (54)
- BE (29)
- CH (28)
- AT (27)
- SE (27)
- NO (18)
- EL (17)
- DK (15)
- IE (15)
- PT (13)
- FI (11)
- PL (10)
- HU (9)
- CZ (7)
- IL (5)
- SI (5)
- CY (4)
- RO (4)
- SK (4)
- EE (3)
- LV (3)
- TR (3)
- BG (2)
- HR (2)
- LT (2)
- AR (1)
- GE (1)
- IS (1)
- KE (1)
- LU (1)
- MT (1)
- RS (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CNRS19 projects · FR
- KU Leuven18 projects · BE
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE15 projects · UK
- TECHNICAL UNIVERSITY OF DENMARK DTU13 projects · DK
- EPFL13 projects · CH
- UCPH13 projects · DK
- POLIMI12 projects · IT
- RIJKSUNIVERSITEIT GRONINGEN11 projects · NL
- UGent11 projects · BE
- CSIC10 projects · ES
- MPG10 projects · DE
- TU Delft10 projects · NL
Projects
Page 16 of 17
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity EDUC8 · 859974 | H2020 | €2,100,702 | €261,500 | Details |
Novel Applications in 19F Magnetic Resonance Imaging NOVA-MRI · 859908 | H2020 | €3,727,829 | €303,173 | Details |
Towards Effective Flow Control and Mitigation of Shock Effects in Aeronautical Applications TEAMAero · 860909 | H2020 | €3,955,104 | €265,620 | Details |
Materials for Neuromorphic Circuits MANIC · 861153 | H2020 | €4,128,381 | €0 | Details |
INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. INSPIRE · 858070 | H2020 | €4,021,969 | €606,345 | Details |
Erythrocytes properties and viability in dependence of flow and extra-cellular environment EVIDENCE · 860436 | H2020 | €3,993,480 | €505,577 | Details |
COnversational BRAins COBRA · 859588 | H2020 | €4,009,380 | €674,812 | Details |
Educating Europe`s Future Engineers in Next Generation Heavy Duty Mobile Machinery: Artificial Intelligence driven Robotisation, Energy Efficiency and Process Optimisation MORE · 858101 | H2020 | €2,175,647 | €211,487 | Details |
Soft, Self-responsive, Smart MAterials for RoboTs SMART · 860108 | H2020 | €3,978,530 | €562,553 | Details |
PancREatic Cancer OrganoiDs rEsearch Network PRECODE · 861196 | H2020 | €3,992,892 | €252,788 | Details |